Floatz logo

Lovastatin

Smith Lemli Opitz Syndrome

Northwestern UniversitySmall moleculePhase 2Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
29/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Smith Lemli Opitz Syndrome cohort.

Asset / SponsorPhaseRating
Cholesterol Suspension
University of Colorado, Denver
Phase 2BB
SIMVASTATIN
Oregon Health and Science University
Phase 2B
CHOLALIC ACID
University of Nebraska
Phase 1/2CCC
Crh
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
D

Same molecule, other indications

Lovastatin is also rated in:

stroke disorderDormant
CC
Indicative ·
47 / 100
View asset →
Malignant MelanomaDormant
CC
Indicative ·
47 / 100
View asset →
obstructive jaundiceDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →